Literature DB >> 21840937

Pharmacokinetics and tissue penetration of vancomycin continuous infusion as prophylaxis for vascular surgery.

Christopher J Payne1, Alison H Thomson, Adam T Stearns, David G Watson, Tong Zhang, David B Kingsmore, Dominique S Byrne, Alexander S Binning.   

Abstract

OBJECTIVES: To determine the tissue penetration of vancomycin into perivascular fat and arterial wall during a continuous infusion of vancomycin, given as prophylaxis for vascular surgery. PATIENTS AND METHODS: Patients undergoing arterial reconstruction requiring antibiotic prophylaxis were included. Patients received a loading infusion of vancomycin the evening prior to surgery followed by a continuous 24 h infusion, calculated according to renal function. Three peri-operative serum samples and intra-operative perivascular fat and arterial wall samples were collected for vancomycin assay.
RESULTS: Twenty-eight patients were included. Three serum samples were obtained from all patients, fat samples were available from 27 (96.4%) patients and vessel wall samples were available from 23 (82.1%) patients. Serum vancomycin concentrations were maintained within a relatively narrow range, while fat and arterial wall concentrations were highly variable.
CONCLUSIONS: This study has shown that prophylactic administration of vancomycin with a loading infusion followed by a continuous infusion before and during vascular surgery achieves serum and vascular tissue concentrations that are above the MICs for most common organisms implicated in post-operative graft infection. However, penetration into perivascular fat tissues is poor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840937     DOI: 10.1093/jac/dkr326

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  CORR Insights®: Vancomycin Prophylaxis for Total Joint Arthroplasty: Incorrectly Dosed and Has a Higher Rate of Periprosthetic Infection Than Cefazolin.

Authors:  Alex Soriano
Journal:  Clin Orthop Relat Res       Date:  2017-04-18       Impact factor: 4.176

2.  Measurement of vancomycin hydrochloride concentration in the exudate from wounds receiving negative pressure wound therapy: a pilot study.

Authors:  Yukiko Ida; Hajime Matsumura; Masami Onishi; Sayaka Ono; Ryutaro Imai; Katsueki Watanabe
Journal:  Int Wound J       Date:  2014-03-28       Impact factor: 3.315

3.  In Vitro Pharmacodynamics of Vancomycin against Methicillin-Susceptible and -Resistant Staphylococcus aureus: Considering the Variability in Observed Tissue Exposure.

Authors:  Yukihiro Hamada; Joseph L Kuti; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2015-11-30       Impact factor: 5.191

4.  Evaluation of Vancomycin Accumulation in Patients With Obesity.

Authors:  Maha S Assadoon; Jeffrey C Pearson; David W Kubiak; Mary P Kovacevic; Brandon W Dionne
Journal:  Open Forum Infect Dis       Date:  2022-09-21       Impact factor: 4.423

Review 5.  Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.

Authors:  Nikolas J Onufrak; Alan Forrest; Daniel Gonzalez
Journal:  Clin Ther       Date:  2016-07-20       Impact factor: 3.393

6.  A Novel Method for the Determination of Vancomycin in Serum by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Application in Patients with Diabetic Foot Infections.

Authors:  Min Liu; Zhi-Hui Yang; Guo-Hui Li
Journal:  Molecules       Date:  2018-11-10       Impact factor: 4.411

7.  Vancomycin-impregnated calcium sulfate beads compared with vancomycin powder in adult spinal deformity patients undergoing thoracolumbar fusion.

Authors:  Grace Xiong; Harold Fogel; Daniel Tobert; Thomas Cha; Joseph Schwab; Christopher Bono; Stuart Hershman
Journal:  N Am Spine Soc J       Date:  2020-12-31

Review 8.  Predicting Antimicrobial Activity at the Target Site: Pharmacokinetic/Pharmacodynamic Indices versus Time-Kill Approaches.

Authors:  Wisse van Os; Markus Zeitlinger
Journal:  Antibiotics (Basel)       Date:  2021-12-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.